// App-Quantinova.ai

: APABETALONE (RVX-208) MODULATES EPIGENETIC PROCESSES IN MONOCYTES AND ENDOTHELIAL CELLS AFFECTED BY DIABETES MELLITUS AND DIET THAT ENHANCE RISK OF CARDIOVASCULAR DISEASE (CVD)

Researchers

Presenter

  • Christopher Halliday

Principal Investigators

  • Laura Tsujikawa

  • Ewelina Kulikowski

  • Cyrus Calosing

  • Sylwia Wasiak

  • Dean Gilham

  • Jan Johansson

  • Mike Sweeney

  • Norman Wong

Medical Centers

  • Resverlogix Corp., Calgary, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Trimethylamine-N-oxide

Drug/Treatment

  • RVX-208

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved